Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study (Q45250281)
Jump to navigation
Jump to search
scientific article published on 7 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study |
scientific article published on 7 October 2013 |
Statements
1 reference
Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study (English)
1 reference
John P Bilezikian
1 reference
Michael Mannstadt
1 reference
Dolores Shoback
1 reference
Maria Luisa Brandi
1 reference
Bart L Clarke
1 reference
Tamara Vokes
1 reference
Lakshminarayan Ranganath
1 reference
William D Fraser
1 reference
Peter Lakatos
1 reference
Laszlo Bajnok
1 reference
Roger Garceau
1 reference
Leif Mosekilde
1 reference
Hjalmar Lagast
1 reference
7 October 2013
1 reference
1 reference
1
1 reference
4
1 reference
275-283
1 reference
Identifiers
1 reference
1 reference